Related Experiment Video

Updated: Jun 27, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
07:31

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Natriuretic peptides: putting the evidence into practice

Ada Andrade1, Haytham Sharar

  • 1St. Michael's Hospital, Toronto, Ontario.

Canadian Journal of Cardiovascular Nursing = Journal Canadien En Soins Infirmiers Cardio-Vasculaires
|December 20, 2008
PubMed

Insights

Natriuretic peptides, such as B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP), aid in diagnosing and managing heart failure. Nurses play a crucial role in utilizing these biomarkers for improved patient care.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Nursing Practice

Background:

  • Increasing longevity with cardiovascular disease leads to higher heart failure incidence and prevalence.
  • Early-stage heart failure misdiagnosis is a significant clinical challenge.
  • Natriuretic peptides are recognized for their value in heart failure diagnosis and management.

Purpose of the Study:

  • To highlight the importance of natriuretic peptides in heart failure.
  • To inform nurses about the clinical applications of BNP and NT-proBNP.
  • To emphasize the role of nurses in leveraging these biomarkers for patient care.

Main Methods:

  • Review of established clinical guidelines and research on natriuretic peptides.
  • Analysis of the diagnostic and therapeutic potential of BNP and NT-proBNP.
  • Focus on the practical application of these peptides in nursing practice.

Main Results:

  • Natriuretic peptides (BNP and NT-proBNP) offer significant value beyond clinical examination for heart failure.
  • These peptides serve as complementary diagnostic tools and potential therapeutic agents.
  • Nurses are key in the effective utilization of natriuretic peptides in heart failure management.

Conclusions:

  • Nurses, as frontline caregivers, must understand the clinical utility of BNP and NT-proBNP.
  • Awareness of natriuretic peptide applications can improve heart failure diagnosis and treatment.
  • Integrating knowledge of these biomarkers enhances nursing's contribution to cardiovascular medicine.

More Related Videos

Isolation of Atrial Myocytes from Adult Mice08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...